在集群随机试验中首次使用电子患者报告的结果指标:一种定性研究
Terese Solvoll Skåre1, Tonje Lundeby2,3, Jo Åsmund Lund4,5
1Department of Health Sciences Ålesund, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Ålesund, Norway. terese.s.skare@ntnu.no.
Journal of patient-reported outcomes
|January 20, 2025
概括
在癌症护理中实施电子患者报告结果测量 (ePROM) 需要解决专业差异并促进合作. 成功的整合取决于管理支持和统一的框架,以克服障碍并最大限度地提高收益.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 在瘤学瘤学.
- 数字健康数字健康
背景情况:
- 患者报告的结果 (PROs) 对癌症治疗至关重要,但它们的整合到常规实践中是有限的.
- 本研究调查了在癌症门诊中实施Eir电子患者报告结果测量 (ePROM) 的促进者和障碍.
- 这项研究还研究了ePROM对医疗保健专业人员工作例程的影响.
研究的目的:
- 探索ePROM实施期间瘤学家和护士所面临的促进者和障碍.
- 评估 Eir ePROM 对参与者的日常工作的影响.
- 确定成功将ePROM整合到常规癌症护理中的关键因素.
主要方法:
- 与九名瘤学家和研究护士进行了半结构化访谈和焦点小组.
- 用感应式和演式方法进行框架分析用于数据分析.
- 实施研究综合框架 (CFIR) 指导了演分析.
主要成果:
- 出现了三个主题:愿意投资,管理层的定,以及建立一个凝聚力的框架.
- 在瘤学家和护士之间,人们注意到他们愿意投入时间和精力方面的差异.
- 管理支持和统一的框架显著影响了实施的成功,关于成本效益的意见各不相同.
结论:
- 成功实施ePROM需要承认不同的医疗保健专业人士的观点.
- 专业间的合作和弥合专业差异对于有效的ePROM集成至关重要.
- 未来的研究应该集中在提高对ePROM价值的共同理解的战略上.
相关概念视频
Methods of Documentation VII: EMR
824
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
824
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K


